Global Gene Site-Directed Mutagenesis Services Supply, Demand and Key Producers, 2026-2032
The global Gene Site-Directed Mutagenesis Services market size is expected to reach $ 274 million by 2032, rising at a market growth of 5.2% CAGR during the forecast period (2026-2032).
Gene Site-Directed Mutagenesis Service is a research outsourcing service based on molecular biology techniques. This service designs specific oligonucleotide primers and uses methods such as PCR (polymerase chain reaction) to introduce precise substitutions, deletions, or insertions at specific nucleotide sites in target genes to simulate naturally occurring mutations or create loss-of-function mutants. Its main purpose is to study the relationship between gene function, protein structure, and activity, or to construct gene expression vectors that meet specific needs. The service provider typically handles the entire process from mutant primer design and plasmid construction to mutant screening and sequencing validation.
The global Gene Site-Directed Mutagenesis Services market is driven by both North America and the Asia-Pacific region. North America, leveraging its mature biotechnology industry chain, boasts numerous specialized companies offering high-throughput, customized mutation services, covering technologies from traditional molecular cloning to advanced CRISPR editing; the market is highly mature. Europe focuses on the integration of technology and basic research, with service providers deeply integrated with structural biology and drug target validation, emphasizing service accuracy and data rigor. The Asia-Pacific region, represented by China, is experiencing rapid growth, utilizing large-scale sequencing platforms and synthetic biology capacity to provide cost-effective, fast services, gradually shifting from low-end contract manufacturing to customized services for complex mutations and model animals.
This report studies the global Gene Site-Directed Mutagenesis Services demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Gene Site-Directed Mutagenesis Services, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Gene Site-Directed Mutagenesis Services that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Gene Site-Directed Mutagenesis Services total market, 2021-2032, (USD Million)
Global Gene Site-Directed Mutagenesis Services total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Gene Site-Directed Mutagenesis Services total market, key domestic companies, and share, (USD Million)
Global Gene Site-Directed Mutagenesis Services revenue by player, revenue and market share 2021-2026, (USD Million)
Global Gene Site-Directed Mutagenesis Services total market by Type, CAGR, 2021-2032, (USD Million)
Global Gene Site-Directed Mutagenesis Services total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Gene Site-Directed Mutagenesis Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Azenta Life Sciences, GenScript, Thermo Fisher Scientific, Charles River Laboratories, Genewiz, Creative Biolabs, NovoPro Bioscience Inc., ACGT, Inc., Epoch Life Science, Eurofins Genomics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Gene Site-Directed Mutagenesis Services market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Gene Site-Directed Mutagenesis Services Market, By Region:
1. How big is the global Gene Site-Directed Mutagenesis Services market?
2. What is the demand of the global Gene Site-Directed Mutagenesis Services market?
3. What is the year over year growth of the global Gene Site-Directed Mutagenesis Services market?
4. What is the total value of the global Gene Site-Directed Mutagenesis Services market?
5. Who are the Major Players in the global Gene Site-Directed Mutagenesis Services market?
6. What are the growth factors driving the market demand?
Gene Site-Directed Mutagenesis Service is a research outsourcing service based on molecular biology techniques. This service designs specific oligonucleotide primers and uses methods such as PCR (polymerase chain reaction) to introduce precise substitutions, deletions, or insertions at specific nucleotide sites in target genes to simulate naturally occurring mutations or create loss-of-function mutants. Its main purpose is to study the relationship between gene function, protein structure, and activity, or to construct gene expression vectors that meet specific needs. The service provider typically handles the entire process from mutant primer design and plasmid construction to mutant screening and sequencing validation.
The global Gene Site-Directed Mutagenesis Services market is driven by both North America and the Asia-Pacific region. North America, leveraging its mature biotechnology industry chain, boasts numerous specialized companies offering high-throughput, customized mutation services, covering technologies from traditional molecular cloning to advanced CRISPR editing; the market is highly mature. Europe focuses on the integration of technology and basic research, with service providers deeply integrated with structural biology and drug target validation, emphasizing service accuracy and data rigor. The Asia-Pacific region, represented by China, is experiencing rapid growth, utilizing large-scale sequencing platforms and synthetic biology capacity to provide cost-effective, fast services, gradually shifting from low-end contract manufacturing to customized services for complex mutations and model animals.
This report studies the global Gene Site-Directed Mutagenesis Services demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Gene Site-Directed Mutagenesis Services, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Gene Site-Directed Mutagenesis Services that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Gene Site-Directed Mutagenesis Services total market, 2021-2032, (USD Million)
Global Gene Site-Directed Mutagenesis Services total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Gene Site-Directed Mutagenesis Services total market, key domestic companies, and share, (USD Million)
Global Gene Site-Directed Mutagenesis Services revenue by player, revenue and market share 2021-2026, (USD Million)
Global Gene Site-Directed Mutagenesis Services total market by Type, CAGR, 2021-2032, (USD Million)
Global Gene Site-Directed Mutagenesis Services total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Gene Site-Directed Mutagenesis Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Azenta Life Sciences, GenScript, Thermo Fisher Scientific, Charles River Laboratories, Genewiz, Creative Biolabs, NovoPro Bioscience Inc., ACGT, Inc., Epoch Life Science, Eurofins Genomics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Gene Site-Directed Mutagenesis Services market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Gene Site-Directed Mutagenesis Services Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Synonymous Mutations
- Missense Mutation
- Nonsense Mutation
- PCR-Mediated Site-Directed Mutagenesis Service
- Homologous Recombination-Based Site-Directed Mutagenesis Service
- Single Primer/Whole Plasmid Amplification-Based Mutagenesis Service
- Function Gain/Loss Service
- Protein Structure Research Service
- Promoter/Regulatory Element Analysis Service
- Resistance/Activity Optimization Service
- Others
- Medical Industry
- Biological Research
- Others
- Azenta Life Sciences
- GenScript
- Thermo Fisher Scientific
- Charles River Laboratories
- Genewiz
- Creative Biolabs
- NovoPro Bioscience Inc.
- ACGT, Inc.
- Epoch Life Science
- Eurofins Genomics
- NZYtech
- Synbio Technologies
- Tsingke
- GenCefe
- Generay
1. How big is the global Gene Site-Directed Mutagenesis Services market?
2. What is the demand of the global Gene Site-Directed Mutagenesis Services market?
3. What is the year over year growth of the global Gene Site-Directed Mutagenesis Services market?
4. What is the total value of the global Gene Site-Directed Mutagenesis Services market?
5. Who are the Major Players in the global Gene Site-Directed Mutagenesis Services market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Gene Site-Directed Mutagenesis Services Introduction
1.2 World Gene Site-Directed Mutagenesis Services Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Gene Site-Directed Mutagenesis Services Total Market by Region (by Headquarter Location)
1.3.1 World Gene Site-Directed Mutagenesis Services Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Gene Site-Directed Mutagenesis Services Revenue (2021-2032)
1.3.3 China Based Company Gene Site-Directed Mutagenesis Services Revenue (2021-2032)
1.3.4 Europe Based Company Gene Site-Directed Mutagenesis Services Revenue (2021-2032)
1.3.5 Japan Based Company Gene Site-Directed Mutagenesis Services Revenue (2021-2032)
1.3.6 South Korea Based Company Gene Site-Directed Mutagenesis Services Revenue (2021-2032)
1.3.7 ASEAN Based Company Gene Site-Directed Mutagenesis Services Revenue (2021-2032)
1.3.8 India Based Company Gene Site-Directed Mutagenesis Services Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Gene Site-Directed Mutagenesis Services Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Gene Site-Directed Mutagenesis Services Consumption Value (2021-2032)
2.2 World Gene Site-Directed Mutagenesis Services Consumption Value by Region
2.2.1 World Gene Site-Directed Mutagenesis Services Consumption Value by Region (2021-2026)
2.2.2 World Gene Site-Directed Mutagenesis Services Consumption Value Forecast by Region (2027-2032)
2.3 United States Gene Site-Directed Mutagenesis Services Consumption Value (2021-2032)
2.4 China Gene Site-Directed Mutagenesis Services Consumption Value (2021-2032)
2.5 Europe Gene Site-Directed Mutagenesis Services Consumption Value (2021-2032)
2.6 Japan Gene Site-Directed Mutagenesis Services Consumption Value (2021-2032)
2.7 South Korea Gene Site-Directed Mutagenesis Services Consumption Value (2021-2032)
2.8 ASEAN Gene Site-Directed Mutagenesis Services Consumption Value (2021-2032)
2.9 India Gene Site-Directed Mutagenesis Services Consumption Value (2021-2032)
3 WORLD GENE SITE-DIRECTED MUTAGENESIS SERVICES COMPANIES COMPETITIVE ANALYSIS
3.1 World Gene Site-Directed Mutagenesis Services Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Gene Site-Directed Mutagenesis Services Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Gene Site-Directed Mutagenesis Services in 2025
3.2.3 Global Concentration Ratios (CR8) for Gene Site-Directed Mutagenesis Services in 2025
3.3 Gene Site-Directed Mutagenesis Services Company Evaluation Quadrant
3.4 Gene Site-Directed Mutagenesis Services Market: Overall Company Footprint Analysis
3.4.1 Gene Site-Directed Mutagenesis Services Market: Region Footprint
3.4.2 Gene Site-Directed Mutagenesis Services Market: Company Product Type Footprint
3.4.3 Gene Site-Directed Mutagenesis Services Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Gene Site-Directed Mutagenesis Services Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Gene Site-Directed Mutagenesis Services Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Gene Site-Directed Mutagenesis Services Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Gene Site-Directed Mutagenesis Services Consumption Value Comparison
4.2.1 United States VS China: Gene Site-Directed Mutagenesis Services Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Gene Site-Directed Mutagenesis Services Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Gene Site-Directed Mutagenesis Services Companies and Market Share, 2021-2026
4.3.1 United States Based Gene Site-Directed Mutagenesis Services Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Gene Site-Directed Mutagenesis Services Revenue, (2021-2026)
4.4 China Based Companies Gene Site-Directed Mutagenesis Services Revenue and Market Share, 2021-2026
4.4.1 China Based Gene Site-Directed Mutagenesis Services Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Gene Site-Directed Mutagenesis Services Revenue, (2021-2026)
4.5 Rest of World Based Gene Site-Directed Mutagenesis Services Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Gene Site-Directed Mutagenesis Services Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Gene Site-Directed Mutagenesis Services Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Gene Site-Directed Mutagenesis Services Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Synonymous Mutations
5.2.2 Missense Mutation
5.2.3 Nonsense Mutation
5.3 Market Segment by Type
5.3.1 World Gene Site-Directed Mutagenesis Services Market Size by Type (2021-2026)
5.3.2 World Gene Site-Directed Mutagenesis Services Market Size by Type (2027-2032)
5.3.3 World Gene Site-Directed Mutagenesis Services Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY TECHNOLOGY
6.1 World Gene Site-Directed Mutagenesis Services Market Size Overview by Technology: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Technology
6.2.1 PCR-Mediated Site-Directed Mutagenesis Service
6.2.2 Homologous Recombination-Based Site-Directed Mutagenesis Service
6.2.3 Single Primer/Whole Plasmid Amplification-Based Mutagenesis Service
6.3 Market Segment by Technology
6.3.1 World Gene Site-Directed Mutagenesis Services Market Size by Technology (2021-2026)
6.3.2 World Gene Site-Directed Mutagenesis Services Market Size by Technology (2027-2032)
6.3.3 World Gene Site-Directed Mutagenesis Services Market Size Market Share by Technology (2027-2032)
7 MARKET ANALYSIS BY FUNCTION
7.1 World Gene Site-Directed Mutagenesis Services Market Size Overview by Function: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Function
7.2.1 Function Gain/Loss Service
7.2.2 Protein Structure Research Service
7.2.3 Promoter/Regulatory Element Analysis Service
7.2.4 Resistance/Activity Optimization Service
7.2.5 Others
7.3 Market Segment by Function
7.3.1 World Gene Site-Directed Mutagenesis Services Market Size by Function (2021-2026)
7.3.2 World Gene Site-Directed Mutagenesis Services Market Size by Function (2027-2032)
7.3.3 World Gene Site-Directed Mutagenesis Services Market Size Market Share by Function (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Gene Site-Directed Mutagenesis Services Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Medical Industry
8.2.2 Biological Research
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World Gene Site-Directed Mutagenesis Services Market Size by Application (2021-2026)
8.3.2 World Gene Site-Directed Mutagenesis Services Market Size by Application (2027-2032)
8.3.3 World Gene Site-Directed Mutagenesis Services Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Azenta Life Sciences
9.1.1 Azenta Life Sciences Details
9.1.2 Azenta Life Sciences Major Business
9.1.3 Azenta Life Sciences Gene Site-Directed Mutagenesis Services Product and Services
9.1.4 Azenta Life Sciences Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Azenta Life Sciences Recent Developments/Updates
9.1.6 Azenta Life Sciences Competitive Strengths & Weaknesses
9.2 GenScript
9.2.1 GenScript Details
9.2.2 GenScript Major Business
9.2.3 GenScript Gene Site-Directed Mutagenesis Services Product and Services
9.2.4 GenScript Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 GenScript Recent Developments/Updates
9.2.6 GenScript Competitive Strengths & Weaknesses
9.3 Thermo Fisher Scientific
9.3.1 Thermo Fisher Scientific Details
9.3.2 Thermo Fisher Scientific Major Business
9.3.3 Thermo Fisher Scientific Gene Site-Directed Mutagenesis Services Product and Services
9.3.4 Thermo Fisher Scientific Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Thermo Fisher Scientific Recent Developments/Updates
9.3.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
9.4 Charles River Laboratories
9.4.1 Charles River Laboratories Details
9.4.2 Charles River Laboratories Major Business
9.4.3 Charles River Laboratories Gene Site-Directed Mutagenesis Services Product and Services
9.4.4 Charles River Laboratories Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Charles River Laboratories Recent Developments/Updates
9.4.6 Charles River Laboratories Competitive Strengths & Weaknesses
9.5 Genewiz
9.5.1 Genewiz Details
9.5.2 Genewiz Major Business
9.5.3 Genewiz Gene Site-Directed Mutagenesis Services Product and Services
9.5.4 Genewiz Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Genewiz Recent Developments/Updates
9.5.6 Genewiz Competitive Strengths & Weaknesses
9.6 Creative Biolabs
9.6.1 Creative Biolabs Details
9.6.2 Creative Biolabs Major Business
9.6.3 Creative Biolabs Gene Site-Directed Mutagenesis Services Product and Services
9.6.4 Creative Biolabs Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Creative Biolabs Recent Developments/Updates
9.6.6 Creative Biolabs Competitive Strengths & Weaknesses
9.7 NovoPro Bioscience Inc.
9.7.1 NovoPro Bioscience Inc. Details
9.7.2 NovoPro Bioscience Inc. Major Business
9.7.3 NovoPro Bioscience Inc. Gene Site-Directed Mutagenesis Services Product and Services
9.7.4 NovoPro Bioscience Inc. Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 NovoPro Bioscience Inc. Recent Developments/Updates
9.7.6 NovoPro Bioscience Inc. Competitive Strengths & Weaknesses
9.8 ACGT, Inc.
9.8.1 ACGT, Inc. Details
9.8.2 ACGT, Inc. Major Business
9.8.3 ACGT, Inc. Gene Site-Directed Mutagenesis Services Product and Services
9.8.4 ACGT, Inc. Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 ACGT, Inc. Recent Developments/Updates
9.8.6 ACGT, Inc. Competitive Strengths & Weaknesses
9.9 Epoch Life Science
9.9.1 Epoch Life Science Details
9.9.2 Epoch Life Science Major Business
9.9.3 Epoch Life Science Gene Site-Directed Mutagenesis Services Product and Services
9.9.4 Epoch Life Science Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Epoch Life Science Recent Developments/Updates
9.9.6 Epoch Life Science Competitive Strengths & Weaknesses
9.10 Eurofins Genomics
9.10.1 Eurofins Genomics Details
9.10.2 Eurofins Genomics Major Business
9.10.3 Eurofins Genomics Gene Site-Directed Mutagenesis Services Product and Services
9.10.4 Eurofins Genomics Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Eurofins Genomics Recent Developments/Updates
9.10.6 Eurofins Genomics Competitive Strengths & Weaknesses
9.11 NZYtech
9.11.1 NZYtech Details
9.11.2 NZYtech Major Business
9.11.3 NZYtech Gene Site-Directed Mutagenesis Services Product and Services
9.11.4 NZYtech Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 NZYtech Recent Developments/Updates
9.11.6 NZYtech Competitive Strengths & Weaknesses
9.12 Synbio Technologies
9.12.1 Synbio Technologies Details
9.12.2 Synbio Technologies Major Business
9.12.3 Synbio Technologies Gene Site-Directed Mutagenesis Services Product and Services
9.12.4 Synbio Technologies Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Synbio Technologies Recent Developments/Updates
9.12.6 Synbio Technologies Competitive Strengths & Weaknesses
9.13 Tsingke
9.13.1 Tsingke Details
9.13.2 Tsingke Major Business
9.13.3 Tsingke Gene Site-Directed Mutagenesis Services Product and Services
9.13.4 Tsingke Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Tsingke Recent Developments/Updates
9.13.6 Tsingke Competitive Strengths & Weaknesses
9.14 GenCefe
9.14.1 GenCefe Details
9.14.2 GenCefe Major Business
9.14.3 GenCefe Gene Site-Directed Mutagenesis Services Product and Services
9.14.4 GenCefe Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 GenCefe Recent Developments/Updates
9.14.6 GenCefe Competitive Strengths & Weaknesses
9.15 Generay
9.15.1 Generay Details
9.15.2 Generay Major Business
9.15.3 Generay Gene Site-Directed Mutagenesis Services Product and Services
9.15.4 Generay Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Generay Recent Developments/Updates
9.15.6 Generay Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Gene Site-Directed Mutagenesis Services Industry Chain
10.2 Gene Site-Directed Mutagenesis Services Upstream Analysis
10.3 Gene Site-Directed Mutagenesis Services Midstream Analysis
10.4 Gene Site-Directed Mutagenesis Services Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Gene Site-Directed Mutagenesis Services Introduction
1.2 World Gene Site-Directed Mutagenesis Services Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Gene Site-Directed Mutagenesis Services Total Market by Region (by Headquarter Location)
1.3.1 World Gene Site-Directed Mutagenesis Services Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Gene Site-Directed Mutagenesis Services Revenue (2021-2032)
1.3.3 China Based Company Gene Site-Directed Mutagenesis Services Revenue (2021-2032)
1.3.4 Europe Based Company Gene Site-Directed Mutagenesis Services Revenue (2021-2032)
1.3.5 Japan Based Company Gene Site-Directed Mutagenesis Services Revenue (2021-2032)
1.3.6 South Korea Based Company Gene Site-Directed Mutagenesis Services Revenue (2021-2032)
1.3.7 ASEAN Based Company Gene Site-Directed Mutagenesis Services Revenue (2021-2032)
1.3.8 India Based Company Gene Site-Directed Mutagenesis Services Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Gene Site-Directed Mutagenesis Services Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Gene Site-Directed Mutagenesis Services Consumption Value (2021-2032)
2.2 World Gene Site-Directed Mutagenesis Services Consumption Value by Region
2.2.1 World Gene Site-Directed Mutagenesis Services Consumption Value by Region (2021-2026)
2.2.2 World Gene Site-Directed Mutagenesis Services Consumption Value Forecast by Region (2027-2032)
2.3 United States Gene Site-Directed Mutagenesis Services Consumption Value (2021-2032)
2.4 China Gene Site-Directed Mutagenesis Services Consumption Value (2021-2032)
2.5 Europe Gene Site-Directed Mutagenesis Services Consumption Value (2021-2032)
2.6 Japan Gene Site-Directed Mutagenesis Services Consumption Value (2021-2032)
2.7 South Korea Gene Site-Directed Mutagenesis Services Consumption Value (2021-2032)
2.8 ASEAN Gene Site-Directed Mutagenesis Services Consumption Value (2021-2032)
2.9 India Gene Site-Directed Mutagenesis Services Consumption Value (2021-2032)
3 WORLD GENE SITE-DIRECTED MUTAGENESIS SERVICES COMPANIES COMPETITIVE ANALYSIS
3.1 World Gene Site-Directed Mutagenesis Services Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Gene Site-Directed Mutagenesis Services Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Gene Site-Directed Mutagenesis Services in 2025
3.2.3 Global Concentration Ratios (CR8) for Gene Site-Directed Mutagenesis Services in 2025
3.3 Gene Site-Directed Mutagenesis Services Company Evaluation Quadrant
3.4 Gene Site-Directed Mutagenesis Services Market: Overall Company Footprint Analysis
3.4.1 Gene Site-Directed Mutagenesis Services Market: Region Footprint
3.4.2 Gene Site-Directed Mutagenesis Services Market: Company Product Type Footprint
3.4.3 Gene Site-Directed Mutagenesis Services Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Gene Site-Directed Mutagenesis Services Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Gene Site-Directed Mutagenesis Services Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Gene Site-Directed Mutagenesis Services Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Gene Site-Directed Mutagenesis Services Consumption Value Comparison
4.2.1 United States VS China: Gene Site-Directed Mutagenesis Services Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Gene Site-Directed Mutagenesis Services Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Gene Site-Directed Mutagenesis Services Companies and Market Share, 2021-2026
4.3.1 United States Based Gene Site-Directed Mutagenesis Services Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Gene Site-Directed Mutagenesis Services Revenue, (2021-2026)
4.4 China Based Companies Gene Site-Directed Mutagenesis Services Revenue and Market Share, 2021-2026
4.4.1 China Based Gene Site-Directed Mutagenesis Services Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Gene Site-Directed Mutagenesis Services Revenue, (2021-2026)
4.5 Rest of World Based Gene Site-Directed Mutagenesis Services Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Gene Site-Directed Mutagenesis Services Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Gene Site-Directed Mutagenesis Services Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Gene Site-Directed Mutagenesis Services Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Synonymous Mutations
5.2.2 Missense Mutation
5.2.3 Nonsense Mutation
5.3 Market Segment by Type
5.3.1 World Gene Site-Directed Mutagenesis Services Market Size by Type (2021-2026)
5.3.2 World Gene Site-Directed Mutagenesis Services Market Size by Type (2027-2032)
5.3.3 World Gene Site-Directed Mutagenesis Services Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY TECHNOLOGY
6.1 World Gene Site-Directed Mutagenesis Services Market Size Overview by Technology: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Technology
6.2.1 PCR-Mediated Site-Directed Mutagenesis Service
6.2.2 Homologous Recombination-Based Site-Directed Mutagenesis Service
6.2.3 Single Primer/Whole Plasmid Amplification-Based Mutagenesis Service
6.3 Market Segment by Technology
6.3.1 World Gene Site-Directed Mutagenesis Services Market Size by Technology (2021-2026)
6.3.2 World Gene Site-Directed Mutagenesis Services Market Size by Technology (2027-2032)
6.3.3 World Gene Site-Directed Mutagenesis Services Market Size Market Share by Technology (2027-2032)
7 MARKET ANALYSIS BY FUNCTION
7.1 World Gene Site-Directed Mutagenesis Services Market Size Overview by Function: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Function
7.2.1 Function Gain/Loss Service
7.2.2 Protein Structure Research Service
7.2.3 Promoter/Regulatory Element Analysis Service
7.2.4 Resistance/Activity Optimization Service
7.2.5 Others
7.3 Market Segment by Function
7.3.1 World Gene Site-Directed Mutagenesis Services Market Size by Function (2021-2026)
7.3.2 World Gene Site-Directed Mutagenesis Services Market Size by Function (2027-2032)
7.3.3 World Gene Site-Directed Mutagenesis Services Market Size Market Share by Function (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Gene Site-Directed Mutagenesis Services Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Medical Industry
8.2.2 Biological Research
8.2.3 Others
8.3 Market Segment by Application
8.3.1 World Gene Site-Directed Mutagenesis Services Market Size by Application (2021-2026)
8.3.2 World Gene Site-Directed Mutagenesis Services Market Size by Application (2027-2032)
8.3.3 World Gene Site-Directed Mutagenesis Services Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Azenta Life Sciences
9.1.1 Azenta Life Sciences Details
9.1.2 Azenta Life Sciences Major Business
9.1.3 Azenta Life Sciences Gene Site-Directed Mutagenesis Services Product and Services
9.1.4 Azenta Life Sciences Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Azenta Life Sciences Recent Developments/Updates
9.1.6 Azenta Life Sciences Competitive Strengths & Weaknesses
9.2 GenScript
9.2.1 GenScript Details
9.2.2 GenScript Major Business
9.2.3 GenScript Gene Site-Directed Mutagenesis Services Product and Services
9.2.4 GenScript Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 GenScript Recent Developments/Updates
9.2.6 GenScript Competitive Strengths & Weaknesses
9.3 Thermo Fisher Scientific
9.3.1 Thermo Fisher Scientific Details
9.3.2 Thermo Fisher Scientific Major Business
9.3.3 Thermo Fisher Scientific Gene Site-Directed Mutagenesis Services Product and Services
9.3.4 Thermo Fisher Scientific Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Thermo Fisher Scientific Recent Developments/Updates
9.3.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
9.4 Charles River Laboratories
9.4.1 Charles River Laboratories Details
9.4.2 Charles River Laboratories Major Business
9.4.3 Charles River Laboratories Gene Site-Directed Mutagenesis Services Product and Services
9.4.4 Charles River Laboratories Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 Charles River Laboratories Recent Developments/Updates
9.4.6 Charles River Laboratories Competitive Strengths & Weaknesses
9.5 Genewiz
9.5.1 Genewiz Details
9.5.2 Genewiz Major Business
9.5.3 Genewiz Gene Site-Directed Mutagenesis Services Product and Services
9.5.4 Genewiz Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Genewiz Recent Developments/Updates
9.5.6 Genewiz Competitive Strengths & Weaknesses
9.6 Creative Biolabs
9.6.1 Creative Biolabs Details
9.6.2 Creative Biolabs Major Business
9.6.3 Creative Biolabs Gene Site-Directed Mutagenesis Services Product and Services
9.6.4 Creative Biolabs Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Creative Biolabs Recent Developments/Updates
9.6.6 Creative Biolabs Competitive Strengths & Weaknesses
9.7 NovoPro Bioscience Inc.
9.7.1 NovoPro Bioscience Inc. Details
9.7.2 NovoPro Bioscience Inc. Major Business
9.7.3 NovoPro Bioscience Inc. Gene Site-Directed Mutagenesis Services Product and Services
9.7.4 NovoPro Bioscience Inc. Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 NovoPro Bioscience Inc. Recent Developments/Updates
9.7.6 NovoPro Bioscience Inc. Competitive Strengths & Weaknesses
9.8 ACGT, Inc.
9.8.1 ACGT, Inc. Details
9.8.2 ACGT, Inc. Major Business
9.8.3 ACGT, Inc. Gene Site-Directed Mutagenesis Services Product and Services
9.8.4 ACGT, Inc. Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 ACGT, Inc. Recent Developments/Updates
9.8.6 ACGT, Inc. Competitive Strengths & Weaknesses
9.9 Epoch Life Science
9.9.1 Epoch Life Science Details
9.9.2 Epoch Life Science Major Business
9.9.3 Epoch Life Science Gene Site-Directed Mutagenesis Services Product and Services
9.9.4 Epoch Life Science Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Epoch Life Science Recent Developments/Updates
9.9.6 Epoch Life Science Competitive Strengths & Weaknesses
9.10 Eurofins Genomics
9.10.1 Eurofins Genomics Details
9.10.2 Eurofins Genomics Major Business
9.10.3 Eurofins Genomics Gene Site-Directed Mutagenesis Services Product and Services
9.10.4 Eurofins Genomics Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Eurofins Genomics Recent Developments/Updates
9.10.6 Eurofins Genomics Competitive Strengths & Weaknesses
9.11 NZYtech
9.11.1 NZYtech Details
9.11.2 NZYtech Major Business
9.11.3 NZYtech Gene Site-Directed Mutagenesis Services Product and Services
9.11.4 NZYtech Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 NZYtech Recent Developments/Updates
9.11.6 NZYtech Competitive Strengths & Weaknesses
9.12 Synbio Technologies
9.12.1 Synbio Technologies Details
9.12.2 Synbio Technologies Major Business
9.12.3 Synbio Technologies Gene Site-Directed Mutagenesis Services Product and Services
9.12.4 Synbio Technologies Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Synbio Technologies Recent Developments/Updates
9.12.6 Synbio Technologies Competitive Strengths & Weaknesses
9.13 Tsingke
9.13.1 Tsingke Details
9.13.2 Tsingke Major Business
9.13.3 Tsingke Gene Site-Directed Mutagenesis Services Product and Services
9.13.4 Tsingke Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Tsingke Recent Developments/Updates
9.13.6 Tsingke Competitive Strengths & Weaknesses
9.14 GenCefe
9.14.1 GenCefe Details
9.14.2 GenCefe Major Business
9.14.3 GenCefe Gene Site-Directed Mutagenesis Services Product and Services
9.14.4 GenCefe Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 GenCefe Recent Developments/Updates
9.14.6 GenCefe Competitive Strengths & Weaknesses
9.15 Generay
9.15.1 Generay Details
9.15.2 Generay Major Business
9.15.3 Generay Gene Site-Directed Mutagenesis Services Product and Services
9.15.4 Generay Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026)
9.15.5 Generay Recent Developments/Updates
9.15.6 Generay Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Gene Site-Directed Mutagenesis Services Industry Chain
10.2 Gene Site-Directed Mutagenesis Services Upstream Analysis
10.3 Gene Site-Directed Mutagenesis Services Midstream Analysis
10.4 Gene Site-Directed Mutagenesis Services Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Gene Site-Directed Mutagenesis Services Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Gene Site-Directed Mutagenesis Services Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Gene Site-Directed Mutagenesis Services Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Gene Site-Directed Mutagenesis Services Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Gene Site-Directed Mutagenesis Services Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Gene Site-Directed Mutagenesis Services Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Gene Site-Directed Mutagenesis Services Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Gene Site-Directed Mutagenesis Services Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Gene Site-Directed Mutagenesis Services Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Gene Site-Directed Mutagenesis Services Players in 2025
Table 12. World Gene Site-Directed Mutagenesis Services Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Gene Site-Directed Mutagenesis Services Company Evaluation Quadrant
Table 14. Head Office of Key Gene Site-Directed Mutagenesis Services Players
Table 15. Gene Site-Directed Mutagenesis Services Market: Company Product Type Footprint
Table 16. Gene Site-Directed Mutagenesis Services Market: Company Product Application Footprint
Table 17. Gene Site-Directed Mutagenesis Services Mergers & Acquisitions Activity
Table 18. United States VS China Gene Site-Directed Mutagenesis Services Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Gene Site-Directed Mutagenesis Services Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Gene Site-Directed Mutagenesis Services Companies, Headquarters (States, Country)
Table 21. United States Based Companies Gene Site-Directed Mutagenesis Services Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Gene Site-Directed Mutagenesis Services Revenue Market Share (2021-2026)
Table 23. China Based Gene Site-Directed Mutagenesis Services Companies, Headquarters (Province, Country)
Table 24. China Based Companies Gene Site-Directed Mutagenesis Services Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Gene Site-Directed Mutagenesis Services Revenue Market Share (2021-2026)
Table 26. Rest of World Based Gene Site-Directed Mutagenesis Services Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Gene Site-Directed Mutagenesis Services Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Gene Site-Directed Mutagenesis Services Revenue Market Share (2021-2026)
Table 29. World Gene Site-Directed Mutagenesis Services Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Gene Site-Directed Mutagenesis Services Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Gene Site-Directed Mutagenesis Services Market Size by Type (2027-2032) & (USD Million)
Table 32. World Gene Site-Directed Mutagenesis Services Market Size by Technology, (USD Million), 2021 & 2025 & 2032
Table 33. World Gene Site-Directed Mutagenesis Services Market Size Value by Technology (2021-2026) & (USD Million)
Table 34. World Gene Site-Directed Mutagenesis Services Market Size by Technology (2027-2032) & (USD Million)
Table 35. World Gene Site-Directed Mutagenesis Services Market Size by Function, (USD Million), 2021 & 2025 & 2032
Table 36. World Gene Site-Directed Mutagenesis Services Market Size Value by Function (2021-2026) & (USD Million)
Table 37. World Gene Site-Directed Mutagenesis Services Market Size by Function (2027-2032) & (USD Million)
Table 38. World Gene Site-Directed Mutagenesis Services Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Gene Site-Directed Mutagenesis Services Market Size by Application (2021-2026) & (USD Million)
Table 40. World Gene Site-Directed Mutagenesis Services Market Size by Application (2027-2032) & (USD Million)
Table 41. Azenta Life Sciences Basic Information, Manufacturing Base and Competitors
Table 42. Azenta Life Sciences Major Business
Table 43. Azenta Life Sciences Gene Site-Directed Mutagenesis Services Product and Services
Table 44. Azenta Life Sciences Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Azenta Life Sciences Recent Developments/Updates
Table 46. Azenta Life Sciences Competitive Strengths & Weaknesses
Table 47. GenScript Basic Information, Manufacturing Base and Competitors
Table 48. GenScript Major Business
Table 49. GenScript Gene Site-Directed Mutagenesis Services Product and Services
Table 50. GenScript Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. GenScript Recent Developments/Updates
Table 52. GenScript Competitive Strengths & Weaknesses
Table 53. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 54. Thermo Fisher Scientific Major Business
Table 55. Thermo Fisher Scientific Gene Site-Directed Mutagenesis Services Product and Services
Table 56. Thermo Fisher Scientific Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Thermo Fisher Scientific Recent Developments/Updates
Table 58. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 59. Charles River Laboratories Basic Information, Manufacturing Base and Competitors
Table 60. Charles River Laboratories Major Business
Table 61. Charles River Laboratories Gene Site-Directed Mutagenesis Services Product and Services
Table 62. Charles River Laboratories Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Charles River Laboratories Recent Developments/Updates
Table 64. Charles River Laboratories Competitive Strengths & Weaknesses
Table 65. Genewiz Basic Information, Manufacturing Base and Competitors
Table 66. Genewiz Major Business
Table 67. Genewiz Gene Site-Directed Mutagenesis Services Product and Services
Table 68. Genewiz Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Genewiz Recent Developments/Updates
Table 70. Genewiz Competitive Strengths & Weaknesses
Table 71. Creative Biolabs Basic Information, Manufacturing Base and Competitors
Table 72. Creative Biolabs Major Business
Table 73. Creative Biolabs Gene Site-Directed Mutagenesis Services Product and Services
Table 74. Creative Biolabs Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Creative Biolabs Recent Developments/Updates
Table 76. Creative Biolabs Competitive Strengths & Weaknesses
Table 77. NovoPro Bioscience Inc. Basic Information, Manufacturing Base and Competitors
Table 78. NovoPro Bioscience Inc. Major Business
Table 79. NovoPro Bioscience Inc. Gene Site-Directed Mutagenesis Services Product and Services
Table 80. NovoPro Bioscience Inc. Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. NovoPro Bioscience Inc. Recent Developments/Updates
Table 82. NovoPro Bioscience Inc. Competitive Strengths & Weaknesses
Table 83. ACGT, Inc. Basic Information, Manufacturing Base and Competitors
Table 84. ACGT, Inc. Major Business
Table 85. ACGT, Inc. Gene Site-Directed Mutagenesis Services Product and Services
Table 86. ACGT, Inc. Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. ACGT, Inc. Recent Developments/Updates
Table 88. ACGT, Inc. Competitive Strengths & Weaknesses
Table 89. Epoch Life Science Basic Information, Manufacturing Base and Competitors
Table 90. Epoch Life Science Major Business
Table 91. Epoch Life Science Gene Site-Directed Mutagenesis Services Product and Services
Table 92. Epoch Life Science Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Epoch Life Science Recent Developments/Updates
Table 94. Epoch Life Science Competitive Strengths & Weaknesses
Table 95. Eurofins Genomics Basic Information, Manufacturing Base and Competitors
Table 96. Eurofins Genomics Major Business
Table 97. Eurofins Genomics Gene Site-Directed Mutagenesis Services Product and Services
Table 98. Eurofins Genomics Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Eurofins Genomics Recent Developments/Updates
Table 100. Eurofins Genomics Competitive Strengths & Weaknesses
Table 101. NZYtech Basic Information, Manufacturing Base and Competitors
Table 102. NZYtech Major Business
Table 103. NZYtech Gene Site-Directed Mutagenesis Services Product and Services
Table 104. NZYtech Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. NZYtech Recent Developments/Updates
Table 106. NZYtech Competitive Strengths & Weaknesses
Table 107. Synbio Technologies Basic Information, Manufacturing Base and Competitors
Table 108. Synbio Technologies Major Business
Table 109. Synbio Technologies Gene Site-Directed Mutagenesis Services Product and Services
Table 110. Synbio Technologies Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Synbio Technologies Recent Developments/Updates
Table 112. Synbio Technologies Competitive Strengths & Weaknesses
Table 113. Tsingke Basic Information, Manufacturing Base and Competitors
Table 114. Tsingke Major Business
Table 115. Tsingke Gene Site-Directed Mutagenesis Services Product and Services
Table 116. Tsingke Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Tsingke Recent Developments/Updates
Table 118. Tsingke Competitive Strengths & Weaknesses
Table 119. GenCefe Basic Information, Manufacturing Base and Competitors
Table 120. GenCefe Major Business
Table 121. GenCefe Gene Site-Directed Mutagenesis Services Product and Services
Table 122. GenCefe Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. GenCefe Recent Developments/Updates
Table 124. GenCefe Competitive Strengths & Weaknesses
Table 125. Generay Basic Information, Manufacturing Base and Competitors
Table 126. Generay Major Business
Table 127. Generay Gene Site-Directed Mutagenesis Services Product and Services
Table 128. Generay Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Generay Recent Developments/Updates
Table 130. Generay Competitive Strengths & Weaknesses
Table 131. Global Key Players of Gene Site-Directed Mutagenesis Services Upstream (Raw Materials)
Table 132. Global Gene Site-Directed Mutagenesis Services Typical Customers
Table 1. World Gene Site-Directed Mutagenesis Services Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Gene Site-Directed Mutagenesis Services Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Gene Site-Directed Mutagenesis Services Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Gene Site-Directed Mutagenesis Services Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Gene Site-Directed Mutagenesis Services Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Gene Site-Directed Mutagenesis Services Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Gene Site-Directed Mutagenesis Services Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Gene Site-Directed Mutagenesis Services Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Gene Site-Directed Mutagenesis Services Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Gene Site-Directed Mutagenesis Services Players in 2025
Table 12. World Gene Site-Directed Mutagenesis Services Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Gene Site-Directed Mutagenesis Services Company Evaluation Quadrant
Table 14. Head Office of Key Gene Site-Directed Mutagenesis Services Players
Table 15. Gene Site-Directed Mutagenesis Services Market: Company Product Type Footprint
Table 16. Gene Site-Directed Mutagenesis Services Market: Company Product Application Footprint
Table 17. Gene Site-Directed Mutagenesis Services Mergers & Acquisitions Activity
Table 18. United States VS China Gene Site-Directed Mutagenesis Services Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Gene Site-Directed Mutagenesis Services Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Gene Site-Directed Mutagenesis Services Companies, Headquarters (States, Country)
Table 21. United States Based Companies Gene Site-Directed Mutagenesis Services Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Gene Site-Directed Mutagenesis Services Revenue Market Share (2021-2026)
Table 23. China Based Gene Site-Directed Mutagenesis Services Companies, Headquarters (Province, Country)
Table 24. China Based Companies Gene Site-Directed Mutagenesis Services Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Gene Site-Directed Mutagenesis Services Revenue Market Share (2021-2026)
Table 26. Rest of World Based Gene Site-Directed Mutagenesis Services Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Gene Site-Directed Mutagenesis Services Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Gene Site-Directed Mutagenesis Services Revenue Market Share (2021-2026)
Table 29. World Gene Site-Directed Mutagenesis Services Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Gene Site-Directed Mutagenesis Services Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Gene Site-Directed Mutagenesis Services Market Size by Type (2027-2032) & (USD Million)
Table 32. World Gene Site-Directed Mutagenesis Services Market Size by Technology, (USD Million), 2021 & 2025 & 2032
Table 33. World Gene Site-Directed Mutagenesis Services Market Size Value by Technology (2021-2026) & (USD Million)
Table 34. World Gene Site-Directed Mutagenesis Services Market Size by Technology (2027-2032) & (USD Million)
Table 35. World Gene Site-Directed Mutagenesis Services Market Size by Function, (USD Million), 2021 & 2025 & 2032
Table 36. World Gene Site-Directed Mutagenesis Services Market Size Value by Function (2021-2026) & (USD Million)
Table 37. World Gene Site-Directed Mutagenesis Services Market Size by Function (2027-2032) & (USD Million)
Table 38. World Gene Site-Directed Mutagenesis Services Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Gene Site-Directed Mutagenesis Services Market Size by Application (2021-2026) & (USD Million)
Table 40. World Gene Site-Directed Mutagenesis Services Market Size by Application (2027-2032) & (USD Million)
Table 41. Azenta Life Sciences Basic Information, Manufacturing Base and Competitors
Table 42. Azenta Life Sciences Major Business
Table 43. Azenta Life Sciences Gene Site-Directed Mutagenesis Services Product and Services
Table 44. Azenta Life Sciences Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Azenta Life Sciences Recent Developments/Updates
Table 46. Azenta Life Sciences Competitive Strengths & Weaknesses
Table 47. GenScript Basic Information, Manufacturing Base and Competitors
Table 48. GenScript Major Business
Table 49. GenScript Gene Site-Directed Mutagenesis Services Product and Services
Table 50. GenScript Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. GenScript Recent Developments/Updates
Table 52. GenScript Competitive Strengths & Weaknesses
Table 53. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 54. Thermo Fisher Scientific Major Business
Table 55. Thermo Fisher Scientific Gene Site-Directed Mutagenesis Services Product and Services
Table 56. Thermo Fisher Scientific Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Thermo Fisher Scientific Recent Developments/Updates
Table 58. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 59. Charles River Laboratories Basic Information, Manufacturing Base and Competitors
Table 60. Charles River Laboratories Major Business
Table 61. Charles River Laboratories Gene Site-Directed Mutagenesis Services Product and Services
Table 62. Charles River Laboratories Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. Charles River Laboratories Recent Developments/Updates
Table 64. Charles River Laboratories Competitive Strengths & Weaknesses
Table 65. Genewiz Basic Information, Manufacturing Base and Competitors
Table 66. Genewiz Major Business
Table 67. Genewiz Gene Site-Directed Mutagenesis Services Product and Services
Table 68. Genewiz Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Genewiz Recent Developments/Updates
Table 70. Genewiz Competitive Strengths & Weaknesses
Table 71. Creative Biolabs Basic Information, Manufacturing Base and Competitors
Table 72. Creative Biolabs Major Business
Table 73. Creative Biolabs Gene Site-Directed Mutagenesis Services Product and Services
Table 74. Creative Biolabs Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Creative Biolabs Recent Developments/Updates
Table 76. Creative Biolabs Competitive Strengths & Weaknesses
Table 77. NovoPro Bioscience Inc. Basic Information, Manufacturing Base and Competitors
Table 78. NovoPro Bioscience Inc. Major Business
Table 79. NovoPro Bioscience Inc. Gene Site-Directed Mutagenesis Services Product and Services
Table 80. NovoPro Bioscience Inc. Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. NovoPro Bioscience Inc. Recent Developments/Updates
Table 82. NovoPro Bioscience Inc. Competitive Strengths & Weaknesses
Table 83. ACGT, Inc. Basic Information, Manufacturing Base and Competitors
Table 84. ACGT, Inc. Major Business
Table 85. ACGT, Inc. Gene Site-Directed Mutagenesis Services Product and Services
Table 86. ACGT, Inc. Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. ACGT, Inc. Recent Developments/Updates
Table 88. ACGT, Inc. Competitive Strengths & Weaknesses
Table 89. Epoch Life Science Basic Information, Manufacturing Base and Competitors
Table 90. Epoch Life Science Major Business
Table 91. Epoch Life Science Gene Site-Directed Mutagenesis Services Product and Services
Table 92. Epoch Life Science Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Epoch Life Science Recent Developments/Updates
Table 94. Epoch Life Science Competitive Strengths & Weaknesses
Table 95. Eurofins Genomics Basic Information, Manufacturing Base and Competitors
Table 96. Eurofins Genomics Major Business
Table 97. Eurofins Genomics Gene Site-Directed Mutagenesis Services Product and Services
Table 98. Eurofins Genomics Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Eurofins Genomics Recent Developments/Updates
Table 100. Eurofins Genomics Competitive Strengths & Weaknesses
Table 101. NZYtech Basic Information, Manufacturing Base and Competitors
Table 102. NZYtech Major Business
Table 103. NZYtech Gene Site-Directed Mutagenesis Services Product and Services
Table 104. NZYtech Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. NZYtech Recent Developments/Updates
Table 106. NZYtech Competitive Strengths & Weaknesses
Table 107. Synbio Technologies Basic Information, Manufacturing Base and Competitors
Table 108. Synbio Technologies Major Business
Table 109. Synbio Technologies Gene Site-Directed Mutagenesis Services Product and Services
Table 110. Synbio Technologies Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Synbio Technologies Recent Developments/Updates
Table 112. Synbio Technologies Competitive Strengths & Weaknesses
Table 113. Tsingke Basic Information, Manufacturing Base and Competitors
Table 114. Tsingke Major Business
Table 115. Tsingke Gene Site-Directed Mutagenesis Services Product and Services
Table 116. Tsingke Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Tsingke Recent Developments/Updates
Table 118. Tsingke Competitive Strengths & Weaknesses
Table 119. GenCefe Basic Information, Manufacturing Base and Competitors
Table 120. GenCefe Major Business
Table 121. GenCefe Gene Site-Directed Mutagenesis Services Product and Services
Table 122. GenCefe Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. GenCefe Recent Developments/Updates
Table 124. GenCefe Competitive Strengths & Weaknesses
Table 125. Generay Basic Information, Manufacturing Base and Competitors
Table 126. Generay Major Business
Table 127. Generay Gene Site-Directed Mutagenesis Services Product and Services
Table 128. Generay Gene Site-Directed Mutagenesis Services Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 129. Generay Recent Developments/Updates
Table 130. Generay Competitive Strengths & Weaknesses
Table 131. Global Key Players of Gene Site-Directed Mutagenesis Services Upstream (Raw Materials)
Table 132. Global Gene Site-Directed Mutagenesis Services Typical Customers
LIST OF FIGURES
Figure 1. Gene Site-Directed Mutagenesis Services Picture
Figure 2. World Gene Site-Directed Mutagenesis Services Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Gene Site-Directed Mutagenesis Services Total Revenue (2021-2032) & (USD Million)
Figure 4. World Gene Site-Directed Mutagenesis Services Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Gene Site-Directed Mutagenesis Services Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Gene Site-Directed Mutagenesis Services Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Gene Site-Directed Mutagenesis Services Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Gene Site-Directed Mutagenesis Services Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Gene Site-Directed Mutagenesis Services Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Gene Site-Directed Mutagenesis Services Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Gene Site-Directed Mutagenesis Services Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Gene Site-Directed Mutagenesis Services Revenue (2021-2032) & (USD Million)
Figure 13. Gene Site-Directed Mutagenesis Services Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Gene Site-Directed Mutagenesis Services Consumption Value (2021-2032) & (USD Million)
Figure 16. World Gene Site-Directed Mutagenesis Services Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Gene Site-Directed Mutagenesis Services Consumption Value (2021-2032) & (USD Million)
Figure 18. China Gene Site-Directed Mutagenesis Services Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Gene Site-Directed Mutagenesis Services Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Gene Site-Directed Mutagenesis Services Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Gene Site-Directed Mutagenesis Services Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Gene Site-Directed Mutagenesis Services Consumption Value (2021-2032) & (USD Million)
Figure 23. India Gene Site-Directed Mutagenesis Services Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Gene Site-Directed Mutagenesis Services by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Gene Site-Directed Mutagenesis Services Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Gene Site-Directed Mutagenesis Services Markets in 2025
Figure 27. United States VS China: Gene Site-Directed Mutagenesis Services Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Gene Site-Directed Mutagenesis Services Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Gene Site-Directed Mutagenesis Services Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Gene Site-Directed Mutagenesis Services Market Size Market Share by Type in 2025
Figure 31. Synonymous Mutations
Figure 32. Missense Mutation
Figure 33. Nonsense Mutation
Figure 34. World Gene Site-Directed Mutagenesis Services Market Size Market Share by Type (2021-2032)
Figure 35. World Gene Site-Directed Mutagenesis Services Market Size by Technology, (USD Million), 2021 & 2025 & 2032
Figure 36. World Gene Site-Directed Mutagenesis Services Market Size Market Share by Technology in 2025
Figure 37. PCR-Mediated Site-Directed Mutagenesis Service
Figure 38. Homologous Recombination-Based Site-Directed Mutagenesis Service
Figure 39. Single Primer/Whole Plasmid Amplification-Based Mutagenesis Service
Figure 40. World Gene Site-Directed Mutagenesis Services Market Size Market Share by Technology (2021-2032)
Figure 41. World Gene Site-Directed Mutagenesis Services Market Size by Function, (USD Million), 2021 & 2025 & 2032
Figure 42. World Gene Site-Directed Mutagenesis Services Market Size Market Share by Function in 2025
Figure 43. Function Gain/Loss Service
Figure 44. Protein Structure Research Service
Figure 45. Promoter/Regulatory Element Analysis Service
Figure 46. Resistance/Activity Optimization Service
Figure 47. Others
Figure 48. World Gene Site-Directed Mutagenesis Services Market Size Market Share by Function (2021-2032)
Figure 49. World Gene Site-Directed Mutagenesis Services Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 50. World Gene Site-Directed Mutagenesis Services Market Size Market Share by Application in 2025
Figure 51. Medical Industry
Figure 52. Biological Research
Figure 53. Others
Figure 54. World Gene Site-Directed Mutagenesis Services Market Size Market Share by Application (2021-2032)
Figure 55. Gene Site-Directed Mutagenesis Services Industrial Chain
Figure 56. Methodology
Figure 57. Research Process and Data Source
Figure 1. Gene Site-Directed Mutagenesis Services Picture
Figure 2. World Gene Site-Directed Mutagenesis Services Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Gene Site-Directed Mutagenesis Services Total Revenue (2021-2032) & (USD Million)
Figure 4. World Gene Site-Directed Mutagenesis Services Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Gene Site-Directed Mutagenesis Services Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Gene Site-Directed Mutagenesis Services Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Gene Site-Directed Mutagenesis Services Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Gene Site-Directed Mutagenesis Services Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Gene Site-Directed Mutagenesis Services Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Gene Site-Directed Mutagenesis Services Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Gene Site-Directed Mutagenesis Services Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Gene Site-Directed Mutagenesis Services Revenue (2021-2032) & (USD Million)
Figure 13. Gene Site-Directed Mutagenesis Services Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Gene Site-Directed Mutagenesis Services Consumption Value (2021-2032) & (USD Million)
Figure 16. World Gene Site-Directed Mutagenesis Services Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Gene Site-Directed Mutagenesis Services Consumption Value (2021-2032) & (USD Million)
Figure 18. China Gene Site-Directed Mutagenesis Services Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Gene Site-Directed Mutagenesis Services Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Gene Site-Directed Mutagenesis Services Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Gene Site-Directed Mutagenesis Services Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Gene Site-Directed Mutagenesis Services Consumption Value (2021-2032) & (USD Million)
Figure 23. India Gene Site-Directed Mutagenesis Services Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Gene Site-Directed Mutagenesis Services by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Gene Site-Directed Mutagenesis Services Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Gene Site-Directed Mutagenesis Services Markets in 2025
Figure 27. United States VS China: Gene Site-Directed Mutagenesis Services Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Gene Site-Directed Mutagenesis Services Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Gene Site-Directed Mutagenesis Services Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Gene Site-Directed Mutagenesis Services Market Size Market Share by Type in 2025
Figure 31. Synonymous Mutations
Figure 32. Missense Mutation
Figure 33. Nonsense Mutation
Figure 34. World Gene Site-Directed Mutagenesis Services Market Size Market Share by Type (2021-2032)
Figure 35. World Gene Site-Directed Mutagenesis Services Market Size by Technology, (USD Million), 2021 & 2025 & 2032
Figure 36. World Gene Site-Directed Mutagenesis Services Market Size Market Share by Technology in 2025
Figure 37. PCR-Mediated Site-Directed Mutagenesis Service
Figure 38. Homologous Recombination-Based Site-Directed Mutagenesis Service
Figure 39. Single Primer/Whole Plasmid Amplification-Based Mutagenesis Service
Figure 40. World Gene Site-Directed Mutagenesis Services Market Size Market Share by Technology (2021-2032)
Figure 41. World Gene Site-Directed Mutagenesis Services Market Size by Function, (USD Million), 2021 & 2025 & 2032
Figure 42. World Gene Site-Directed Mutagenesis Services Market Size Market Share by Function in 2025
Figure 43. Function Gain/Loss Service
Figure 44. Protein Structure Research Service
Figure 45. Promoter/Regulatory Element Analysis Service
Figure 46. Resistance/Activity Optimization Service
Figure 47. Others
Figure 48. World Gene Site-Directed Mutagenesis Services Market Size Market Share by Function (2021-2032)
Figure 49. World Gene Site-Directed Mutagenesis Services Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 50. World Gene Site-Directed Mutagenesis Services Market Size Market Share by Application in 2025
Figure 51. Medical Industry
Figure 52. Biological Research
Figure 53. Others
Figure 54. World Gene Site-Directed Mutagenesis Services Market Size Market Share by Application (2021-2032)
Figure 55. Gene Site-Directed Mutagenesis Services Industrial Chain
Figure 56. Methodology
Figure 57. Research Process and Data Source
